These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30200625)

  • 21. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX.
    Aneja B; Queen A; Khan P; Shamsi F; Hussain A; Hasan P; Rizvi MMA; Daniliuc CG; Alajmi MF; Mohsin M; Hassan MI; Abid M
    Bioorg Med Chem; 2020 May; 28(9):115424. PubMed ID: 32209296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
    De Luca L; Mancuso F; Ferro S; Buemi MR; Angeli A; Del Prete S; Capasso C; Supuran CT; Gitto R
    Eur J Med Chem; 2018 Jan; 143():276-282. PubMed ID: 29197732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH; Zaki MA
    Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.
    Coviello V; Marchi B; Sartini S; Quattrini L; Marini AM; Simorini F; Taliani S; Salerno S; Orlandi P; Fioravanti A; Desidero TD; Vullo D; Da Settimo F; Supuran CT; Bocci G; La Motta C
    J Med Chem; 2016 Jul; 59(13):6547-52. PubMed ID: 27305384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
    Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
    Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
    El-Gamal MI; Oh CH
    Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K; Bindal S; Luxami V
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
    Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
    Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis and Cytotoxicity of New Coumarin-1,2,3-triazole Derivatives: Evaluation of Anticancer Activity and Molecular Docking Studies.
    Premsagar Miriyala V; Raj Thommandru P; Kashanna J; Govinda V; Ravi G; Kishore R
    Chem Biodivers; 2023 Jul; 20(7):e202300269. PubMed ID: 37204157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
    Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
    Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
    Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
    J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
    Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
    Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity.
    Angeli A; Trallori E; Ferraroni M; Di Cesare Mannelli L; Ghelardini C; Supuran CT
    Eur J Med Chem; 2018 Sep; 157():1214-1222. PubMed ID: 30193219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
    Mamatha SV; Belagali SL; Bhat M; Kumbar VM
    Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
    Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
    Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
    Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.